Ankylosing spondylitis (AS) is an inflammatory disease of the spine and sometimes the eyes, joints, and other organs. Intestinal carriage of klebsiella, and infection with organisms such as salmonella and yersinia may play a part in triggering the disease, although susceptibility is conferred by the HLA-B27 antigen and preexisting psoriasis, ulcerative colitis, or Crohn's disease.' How the spine and sometimes joints, heart, and lungs become the targets remains uncertain, but sensitised T lymphocytes are thought to mediate damage, possibly reacting against an antigen expressed at the cell surface in association with HLA-B27 itself. Serological autoimmune responses are well known in other inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and the connective tissue diseases, but antibody responses in AS have received less attention. Increased levels of serum IgA are well recognised in some patients, autoantibodies to HLA-B27 have been reported,2 and antibodies to bacteria have been studied. 3 There is one report of a specific antibody response in AS, directed at heat shock puffs of Drosophila melanogaster larvae. 4 Heat shock, warming cells a few degrees above their physiological temperature, and various other physical and chemical stresses cause a reduction in the synthesis of many cellular proteins and increased synthesis of the so called heat shock or stress proteins. The heat shock response has been observed in every organism studied from bacteria to humans, and heat shock genes are highly conserved.5 The response is protective overall, and some heat shock proteins act as molecular chaperones maintaining the solubility of immature proteins during the final stages of synthesis and transport.' Synthesis of heat shock proteins is a normal cellular function which is amplified under conditions of physiological stress, perhaps to protect proteins from denaturation. One particular heat shock protein, hsp65, is a dominant antigen in the immune response to microorganisms. ' The heat shock phenomenon was first observed as the development of chromosomal puffs in Drosophila melanogaster larvae.8 Using such chromosomes as substrate for immunofluorescence, Lakomek et al4 observed that serum samples from 39% of patients with AS contained an antibody which reacted with heat shock puffs, especially the chromosomal 93D locus. In preliminary experiments we confirmed this finding, but the procedure was technically demanding, difficult to standardise, and in our hands not suitable for the investigation of large numbers of serum samples (Hilton J, Bernstein R M, unpublished data). This report describes our findings with an immunoblotting system for the detection of antibodies to insect proteins. We studied an antibody to a 63 kilodalton protein from insect cells and investigated the cross reactivity with a well characterised mycobacterial heat shock protein of similar molecular weight, hsp65. protein of this size, the result with ML-30 suggested that the 63 kilodalton antigen identified by serum samples from patients with AS might be cross reactive with the well characterised mycobacterial heat shock protein of similar molecular weight. Therefore, we measured the binding of serum samples from patients with AS to recombinant mycobacterial hsp65 by ELISA. As shown in fig 3A, B, and C, there was a wide range of binding of serum samples from patients with AS, RA, SLE, and healthy control subjects. The most striking abnormality (shown in fig 3C) was for patients with AS. Nineteen (41%) of 46 serum samples showed increased IgA binding to the recombinant mycobacterial hsp65 antigen (greater than two standard deviations above that of healthy control subjects), and the mean binding of IgA from patients with AS was higher than for controls (p<0001, Mann-Whitney U test). Serum IgA levels in the AS group (mean 3-4 g/l, SD 2 0) were also significantly higher than the control group (mean 2-1 g/l, SD 0-9, p<0 01, Student's t test), and fig 3B illustrates the correlation between total IgA and IgA class binding to hsp65 (Pearson's coefficient of rank correlation r=0-69, p<0 001).
In patients with RA the IgA binding to hsp65 was not significantly different from the control group (Mann-Whitney U test), although binding was increased in four of 19 serum samples (21%). In a further study of patients with particularly severe rheumatoid disease (vasculitis, fibrosing alveolitis, bronchiectasis, or Felty's syndrome) the frequency of increased IgA binding to hsp65 was 29-4% of 85 patients (data not shown). IgG binding to hsp65 in patients with RA was increased in six (31%) of 19 serum samples (p<005 versus controls, fig  3) and 13 (15%) of the further 85 serum samples (data not shown). None of the groups showed increased IgM binding.
In AS antibodies to hsp65 and to the 63 kilodalton insect protein were found in 41 and 46% of patients respectively, but there was no correlation between the two. Eight patients had antibodies that recognised both proteins, 15 patients had antibodies to neither, and the remainder had antibodies to only one of the proteins (10 to hsp65, 12 to the 63 kilodalton protein). 
